High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors
- 1 May 2003
- journal article
- other
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (7) , 1108-1110
- https://doi.org/10.1097/00002030-200305020-00030
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adultsAIDS, 2001
- Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individualsAIDS, 2000
- Indinavir Concentrations and Antiviral EffectPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Urological complaints in relation to indinavir plasma concentrations in HIV-infected patientsAIDS, 1999
- Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patientsAIDS, 1998
- Pharmacokinetic Interaction between Ritonavir and Indinavir in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 1998
- Low Plasma Concentrations of Indinavir are Related to Virological Treatment Failure in HIV-1-Infected Patients on Indinavir-Containing Triple TherapyAntiviral Therapy, 1998
- Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switchingJournal of Chromatography A, 1995